Issue 1, 2015

Design and synthesis of potent hydroxamate inhibitors with increased selectivity within the gelatinase family

Abstract

MMP-2 is a validated target for the development of anticancer agents. Herein we describe the synthesis of a new series of potent phenylalanine derived hydroxamates, with increased MMP-2/MMP-9 selectivity compared to analogous hydroxamates described previously. Docking and molecular dynamics experiments have been used to account for this selectivity, and to clarify the role of the triazole ring in the binding process.

Graphical abstract: Design and synthesis of potent hydroxamate inhibitors with increased selectivity within the gelatinase family

Supplementary files

Article information

Article type
Paper
Submitted
18 Jul 2014
Accepted
01 Oct 2014
First published
01 Oct 2014

Org. Biomol. Chem., 2015,13, 142-156

Design and synthesis of potent hydroxamate inhibitors with increased selectivity within the gelatinase family

J. M. Zapico, A. Puckowska, K. Filipiak, C. Coderch, B. de Pascual-Teresa and A. Ramos, Org. Biomol. Chem., 2015, 13, 142 DOI: 10.1039/C4OB01516A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements